Boston Scientific (NYSE:BSX) must pay $42 million in unpaid royalties to TissueGen and the University of Texas, a federal jury in Delaware has ruled. The jury verdict yesterday came after the finding that Boston Scientific’s Synergy BP drug-eluting stents infringed on TissueGen and the university’s IP. The patent under question arose out of research that […]
TissueGen
Tackling drug delivery challenges with TissueGen’s implantable fibers
TissueGen‘s chief scientist and co-founder, Kevin Nelson, told Drug Delivery Business News the story behind the company he founded in 2000 and its drug delivery technology, the Elute fiber. DDBN: How did TissueGen get its start? Nelson: In 1996, while faculty in biomedical engineering at The University of Texas at Arlington, I was working with […]
11 companies with interesting technology at MD&M East
Thousands of engineers and executives are expected to descend on the Javits Center in New York next week for MD&M East, the largest medical device manufacturing event on the East Coast. Fun attractions include Apple co-founder Steve “Woz” Wozniak delivering a keynote speech, the 19th annual Medical Design Excellence Awards, robot battles and a 3D printed […]
Medtronic shuffles the deck | Personnel Moves
Medtronic (NYSE:MDT) today said it named Geoff Martha to be the new president of its restorative therapies division, replacing Christopher O’Connell, who left to take the CEO spot at Waters Corp. Martha is slated to be replaced in the chief integration officer role by Bill Burke, who joined Medtronic as part of its $50 billion acquisition […]